{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:47:22Z","timestamp":1767988042083,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.amsu.2020.12.030","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T17:32:36Z","timestamp":1609176756000},"page":"122-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis"],"prefix":"10.1097","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-3746","authenticated-orcid":false,"given":"Khan","family":"Sharun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"10.1016\/j.amsu.2020.12.030_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019-COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.amsu.2020.12.030_bib2","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"issue":"557","key":"10.1016\/j.amsu.2020.12.030_bib3","doi-asserted-by":"crossref","first-page":"eabc5332","DOI":"10.1126\/scitranslmed.abc5332","article-title":"3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice","volume":"12","author":"Rathnayake","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.amsu.2020.12.030_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1098612X17729626","article-title":"Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis","volume":"20","author":"Pedersen","year":"2018","journal-title":"J. Feline Med. Surg."},{"issue":"1","key":"10.1016\/j.amsu.2020.12.030_bib5","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.amsu.2020.12.030_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/01652176.2020.1845917","article-title":"Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats","volume":"40","author":"Izes","year":"2020","journal-title":"Vet. Q."},{"key":"10.1016\/j.amsu.2020.12.030_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.13856","article-title":"Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): are they similar?","author":"Paltrinieri","year":"2020","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.amsu.2020.12.030_bib8","doi-asserted-by":"crossref","first-page":"584673","DOI":"10.3389\/fvets.2020.584673","article-title":"Coronavirus infection of the central nervous system: animal models in the time of COVID-19","volume":"7","author":"Dickinson","year":"2020","journal-title":"Front Vet Sci"},{"issue":"4","key":"10.1016\/j.amsu.2020.12.030_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jvim.15780","article-title":"Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis","volume":"34","author":"Dickinson","year":"2020","journal-title":"J. Vet. Intern. Med."},{"issue":"8","key":"10.1016\/j.amsu.2020.12.030_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.amsu.2020.12.030_bib11","first-page":"2535","article-title":"Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.amsu.2020.12.030_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2018.10.015","article-title":"Protease inhibitors broadly effective against feline, ferret and mink coronaviruses","volume":"160","author":"Perera","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.amsu.2020.12.030_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0751","article-title":"Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L","author":"Sacco","year":"2020","journal-title":"Sci Adv"}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S204908012030546X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S204908012030546X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:06:49Z","timestamp":1677082009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S204908012030546X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":13,"alternative-id":["S204908012030546X"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2020.12.030","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2020.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}